666 followers
RT @RespiratoryBMC: New article: Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive…
RT @RespiratoryBMC: New article: Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive…
#respiratoryresearch Maintained therapeutic effect of revefenacin over 52 weeks in moderate… https://t.co/pEfEkepzrP
New article: Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD) https://t.co/TmfyqDbjWe